{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:35:20Z","timestamp":1778571320154,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":927,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.jcf.2010.09.003","type":"journal-article","created":{"date-parts":[[2010,10,4]],"date-time":"2010-10-04T09:53:58Z","timestamp":1286186038000},"page":"25-30","source":"Crossref","is-referenced-by-count":27,"title":["Twice vs three-times daily antibiotics in the treatment of pulmonary exacerbations of cystic fibrosis"],"prefix":"10.1016","volume":"10","author":[{"given":"D.","family":"Adeboyeku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.","family":"Hodson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jcf.2010.09.003_bb0005","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jpeds.2009.05.005","article-title":"Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening","volume":"155","author":"Stick","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2010.09.003_bb0010","unstructured":"Cystic Fibrosis Foundation Patient Registry: Annual Data Report 2007."},{"issue":"4","key":"10.1016\/j.jcf.2010.09.003_bb0015","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1034\/j.1399-3003.2000.16d30.x","article-title":"Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus","volume":"16","author":"Doring","year":"2000","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.jcf.2010.09.003_bb0020","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jcf.2010.09.003_bb0025","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/jac\/39.6.677","article-title":"Once-daily dosing of aminoglycosides: review and recommendations for clinical practice","volume":"39","author":"Freeman","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.jcf.2010.09.003_bb0030","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/adc.78.6.536","article-title":"Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis","volume":"78","author":"Vic","year":"1998","journal-title":"Arch Dis Child"},{"issue":"9459","key":"10.1016\/j.jcf.2010.09.003_bb0035","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(05)17906-9","article-title":"Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis\u2014the TOPIC study: a randomised controlled trial","volume":"365","author":"Smyth","year":"2005","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jcf.2010.09.003_bb0040","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s15010-009-8117-4","article-title":"Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients","volume":"37","author":"Riethmueller","year":"2009","journal-title":"Infection"},{"key":"10.1016\/j.jcf.2010.09.003_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-1993(08)60141-1","article-title":"Ototoxicity following once daily aminoglycoside administration in adults with CF","volume":"7","author":"Elston","year":"2008","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2010.09.003_bb0050","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jcf.2007.07.001","article-title":"Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis","volume":"7","author":"Latzin","year":"2008","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2010.09.003_bb0055","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1378\/chest.128.4.2336","article-title":"The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis","volume":"128","author":"Blumer","year":"2005","journal-title":"Chest"},{"issue":"9484","key":"10.1016\/j.jcf.2010.09.003_bb0060","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(05)67060-2","article-title":"Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial","volume":"366","author":"Aaron","year":"2005","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jcf.2010.09.003_bb0065","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s15010-009-8116-5","article-title":"Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis","volume":"37","author":"Riethmueller","year":"2009","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.jcf.2010.09.003_bb0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jac\/40.1.125","article-title":"Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: clinical outcome, microbiology and pharmacokinetics","volume":"40","author":"Vinks","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.jcf.2010.09.003_bb0075","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/PL00008370","article-title":"Continuous infusion of ceftazidime with a portable pump is as effective as thrice-a-day bolus in cystic fibrosis children","volume":"159","author":"Rappaz","year":"2000","journal-title":"Eur J Pediatr"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199310001384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199310001384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T16:20:24Z","timestamp":1544199624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199310001384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1569199310001384"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2010.09.003","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}